Trial
NCT06548620
A Study of RD06-04 in Patients With Active Autoimmune Diseases
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Nanjing Bioheng Biotech Co., Ltd.
Collaborators
—
Condition
SLE
Intervention
RD06-04 cell infusion
Why stopped
R\&D strategy adjustment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-03